SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-162074
Filing Date
2015-04-30
Accepted
2015-04-30 16:27:12
Documents
15
Period of Report
2015-06-19
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d910154ddef14a.htm DEF 14A 480065
2 GRAPHIC g910154g37a73.jpg GRAPHIC 181600
3 GRAPHIC g910154g51a38.jpg GRAPHIC 180209
4 GRAPHIC g910154g79v24.jpg GRAPHIC 2912
5 GRAPHIC g910154line.jpg GRAPHIC 441
6 GRAPHIC g910154p1.jpg GRAPHIC 264884
7 GRAPHIC g910154p2.jpg GRAPHIC 131737
8 GRAPHIC g910154tx_pg1.jpg GRAPHIC 106260
9 GRAPHIC g910154tx_pg2.jpg GRAPHIC 183968
10 GRAPHIC g910154tx_pg3.jpg GRAPHIC 167484
11 GRAPHIC g910154tx_pg4a.jpg GRAPHIC 7885
12 GRAPHIC g910154tx_pg4b.jpg GRAPHIC 5126
13 GRAPHIC g910154tx_pg6a.jpg GRAPHIC 3836
14 GRAPHIC g910154tx_pg6b.jpg GRAPHIC 1722
15 GRAPHIC g910154tx_pg6c.jpg GRAPHIC 2552
  Complete submission text file 0001193125-15-162074.txt   2192805
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 15819108
SIC: 2834 Pharmaceutical Preparations